The US-FDA said the first Covid-19 vaccine being considered for US distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.

 

An outside panel of scientific advisers will review the FDA report Thursday, along with a companion analysis from the vaccine’s manufacturers, Pfizer Inc. and German partner BioNTech SE. A favorable recommendation from the panel is expected to be followed within a few days by the FDA granting emergency authorization for the vaccine.

 

https://www.fda.gov/media/144246/download

Read more: https://www.fda.gov/media/144246/download